| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer treatments. Its flagship product is Plinabulin, a selective immune-modulating and microtubule-binding agent. Plinabulin has successfully advanced through Phase III clinical trials for two distinct applications: the prevention of chemotherapy-induced neutropenia, and the treatment of advanced non-small cell lung cancer. The company is also exploring Plinabulin's efficacy in combination with various immuno-oncology drugs; specifically, alongside …
Over the last 12 months, insiders at BeyondSpring Inc. have bought $0 and sold $0 worth of BeyondSpring Inc. stock.
On average, over the past 5 years, insiders at BeyondSpring Inc. have bought $0 and sold $2.02M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2025-10-17 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 45,513 0.1324% | $1.76 | $80,103 | -11.30% | |
| 2025-10-16 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 85,798 0.2439% | $1.72 | $147,573 | -12.29% | |
| 2025-10-15 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 17,960 0.049% | $1.65 | $29,634 | -4.85% | |
| 2025-10-14 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 28,495 0.0777% | $1.65 | $47,017 | -3.66% | |
| 2025-10-13 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 107,361 0.3017% | $1.70 | $182,514 | -7.02% | |
| 2025-10-10 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 2,390 0.007% | $1.77 | $4,230 | -8.62% | |
| 2025-10-09 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 3,979 0.0119% | $1.81 | $7,202 | -12.15% | |
| 2025-10-08 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 7,507 0.022% | $1.77 | $13,287 | -10.61% | |
| 2025-10-07 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 2,100 0.0062% | $1.79 | $3,759 | -11.11% | |
| 2025-10-06 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 17,500 0.0515% | $1.78 | $31,150 | -10.11% | |
| 2025-10-03 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 600 0.0017% | $1.76 | $1,056 | -8.29% | |
| 2025-10-02 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 600 0.0017% | $1.73 | $1,038 | -6.94% | |
| 2025-10-01 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 2,601 0.0077% | $1.80 | $4,682 | -10.06% | |
| 2025-09-30 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 4,464 0.0134% | $1.81 | $8,080 | -11.05% | |
| 2025-09-29 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 500 0.0014% | $1.75 | $875 | -7.47% | |
| 2025-09-26 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 600 0.0017% | $1.68 | $1,008 | -8.24% | |
| 2025-09-25 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 700 0.0019% | $1.66 | $1,162 | -3.57% | |
| 2025-09-24 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 2,256 0.0063% | $1.68 | $3,790 | -4.14% | |
| 2025-09-23 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 4,106 0.0117% | $1.72 | $7,062 | -2.41% | |
| 2025-09-22 | Sale | Decheng Capital China Life Sciences USD Fund III, L.P. | 10 percent owner | 5,410 0.0164% | $1.83 | $9,900 | -9.50% |
| Increased Positions | 11 | +55% | 558,325 | +9.43% |
| Decreased Positions | 7 | -35% | 492,626 | -8.32% |
| New Positions | 6 | New | 261,105 | New |
| Sold Out Positions | <1 | Sold Out | 1,080 | Sold Out |
| Total Postitions | 24 | +20% | 6M | +1.11% |